Head-to-head comparison
Andrew Meds vs Boston Medical Group
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Andrew Meds prices both molecules openly and says which 44 states can be treated by questionnaire alone — then routes every Get Started button on its semaglutide page to a different, cheaper program.
From $199/mo sema · From $299/mo tirz · Verified September 2026
Marked down on: Every Get Started button on the compounded semaglutide page opens a microdosing program at $99 a month, and that word appears nowhere else on the site.
Desk Score
Boston Medical Group is an established medical group running a 12-week compounded GLP-1 weight-loss program.
From $199/mo (lowest dose rung) sema · Verified August 2026
Marked down on: The published rate is a range by dose strength, $199 to $299, so the figure quoted is the floor rather than what a titrated patient pays
Andrew Meds takes this head-to-head with the higher Desk Score, 79/100 (C+) against 67/100 (C) for Boston Medical Group. Boston Medical Group still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Andrew Meds
79/100
C+
Boston Medical Group
67/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Andrew Meds | Boston Medical Group |
|---|---|---|
| Semaglutide | From $199/moFrom $199/mo (compounded) | From $199/molowest dose rung$199/mo (starting strength, rising with dose, compounded) |
| Tirzepatide | From $299/moFrom $299/mo (compounded) | Not listed on Boston Medical Group's site (checked August 2026) |
| Coverage | All 50 states and D.C. (44 by questionnaire, the rest by live visit) | 7 states |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Anyone who will confirm which program the checkout actually opened before paying for it. | People who want a clinician-run 12-week program and can accept a price quoted as a range rather than a rate. |
| Desk Score | 79/100C+ | 67/100C |
The verdict
Desk pick — Andrew MedsAndrew Meds takes this head-to-head with the higher Desk Score, 79/100 (C+) against 67/100 (C) for Boston Medical Group. Boston Medical Group still holds its ground where its strengths line up with yours.
Choose Andrew Meds if…
Anyone who will confirm which program the checkout actually opened before paying for it.
From $199/mo sema · From $299/mo tirz · All 50 states and D.C. (44 by questionnaire, the rest by live visit)
Choose Boston Medical Group if…
People who want a clinician-run 12-week program and can accept a price quoted as a range rather than a rate.
From $199/mo (lowest dose rung) sema · 7 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Andrew Meds · Boston Medical Group.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- Andrew Meds vs CoreAge Rx
- Boston Medical Group vs CoreAge Rx
- Andrew Meds vs HealthRX
- Boston Medical Group vs HealthRX
- Andrew Meds vs Breeze Meds
- Boston Medical Group vs Breeze Meds
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.